Honeysuckle-derived miR2911 exhibits anti-tumor effects in colon cancer by targeting TGF-β1 mRNA in tumor-bearing wild type Sidt1+/+ and nude type Sidt1-/- mouse models [91]. This evidence concerns the gene SIDT1 and neoplasm.